A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's Lymphoma

Clinical trial NCT00636311 · COMPLETED

Trial details

NCT number: NCT00636311
Sponsor: Istituto Clinico Humanitas
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Disease

Start date: 2008-02-01
Primary completion: 2008-04-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.